• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中巨噬细胞和 T 细胞代谢重编程及免疫治疗的研究进展

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.

机构信息

Department of Gastrointestinal Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

出版信息

PeerJ. 2024 Jan 15;12:e16825. doi: 10.7717/peerj.16825. eCollection 2024.

DOI:10.7717/peerj.16825
PMID:38239299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10795528/
Abstract

Macrophages and T cells in the tumor microenvironment (TME) play an important role in tumorigenesis and progression. However, TME is also characterized by metabolic reprogramming, which may affect macrophage and metabolic activity of T cells and promote tumor escape. Immunotherapy is an approach to fight tumors by stimulating the immune system in the host, but requires support and modulation of cellular metabolism. In this process, the metabolic roles of macrophages and T cells become increasingly important, and their metabolic status and interactions play a critical role in the success of immunotherapy. Therefore, understanding the metabolic state of T cells and macrophages in the TME and the impact of metabolic reprogramming on tumor therapy will help optimize subsequent immunotherapy strategies.

摘要

肿瘤微环境(TME)中的巨噬细胞和 T 细胞在肿瘤发生和进展中发挥着重要作用。然而,TME 还具有代谢重编程的特点,这可能会影响巨噬细胞和 T 细胞的代谢活性,并促进肿瘤逃逸。免疫疗法是一种通过刺激宿主免疫系统来对抗肿瘤的方法,但需要细胞代谢的支持和调节。在这个过程中,巨噬细胞和 T 细胞的代谢作用变得越来越重要,它们的代谢状态和相互作用对免疫疗法的成功起着关键作用。因此,了解 TME 中 T 细胞和巨噬细胞的代谢状态以及代谢重编程对肿瘤治疗的影响,将有助于优化后续的免疫疗法策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/62da8de3aa58/peerj-12-16825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/144f4531496d/peerj-12-16825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/f21f9486798f/peerj-12-16825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/62da8de3aa58/peerj-12-16825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/144f4531496d/peerj-12-16825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/f21f9486798f/peerj-12-16825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/018d/10795528/62da8de3aa58/peerj-12-16825-g003.jpg

相似文献

1
Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.肿瘤微环境中巨噬细胞和 T 细胞代谢重编程及免疫治疗的研究进展
PeerJ. 2024 Jan 15;12:e16825. doi: 10.7717/peerj.16825. eCollection 2024.
2
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.没食子儿茶素没食子酸酯在肿瘤微环境、代谢重编程和免疫治疗中的作用。
Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024.
3
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.肿瘤免疫微环境代谢重编程在结直肠癌进展、免疫逃逸和免疫治疗反应中的作用。
Front Immunol. 2024 Jul 25;15:1353787. doi: 10.3389/fimmu.2024.1353787. eCollection 2024.
4
The Role of Tumor Metabolic Reprogramming in Tumor Immunity.肿瘤代谢重编程在肿瘤免疫中的作用。
Int J Mol Sci. 2023 Dec 13;24(24):17422. doi: 10.3390/ijms242417422.
5
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.2003 年至 2022 年肿瘤微环境代谢重编程的文献计量分析。
Cancer Rep (Hoboken). 2024 Aug;7(8):e2146. doi: 10.1002/cnr2.2146.
6
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.靶向肿瘤相关巨噬细胞的脂质代谢重编程:癌症免疫治疗的新视角。
Cell Oncol (Dordr). 2024 Apr;47(2):415-428. doi: 10.1007/s13402-023-00881-y. Epub 2023 Sep 30.
7
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.利用代谢重编程来改善癌症免疫疗法。
Int J Mol Sci. 2021 Sep 24;22(19):10268. doi: 10.3390/ijms221910268.
8
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.肿瘤微环境的代谢重编程以增强免疫疗法。
BMB Rep. 2024 Sep;57(9):388-399. doi: 10.5483/BMBRep.2024-0031.
9
Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.肿瘤微环境中自然杀伤细胞代谢重编程对自然杀伤细胞疗法影响的研究进展
J Transl Med. 2024 Mar 3;22(1):229. doi: 10.1186/s12967-024-05033-w.
10
Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.代谢重编程在肿瘤免疫逃逸和免疫治疗中的新作用。
Sci China Life Sci. 2021 Apr;64(4):534-547. doi: 10.1007/s11427-019-1735-4. Epub 2020 Aug 17.

引用本文的文献

1
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review.肿瘤浸润细胞免疫功能悖论及其免疫治疗靶点的当前进展:一篇综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 10. doi: 10.1007/s00210-025-03985-4.

本文引用的文献

1
CAR T therapy beyond cancer: the evolution of a living drug.CAR T 疗法超越癌症:活药物的演变。
Nature. 2023 Jul;619(7971):707-715. doi: 10.1038/s41586-023-06243-w. Epub 2023 Jul 26.
2
Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma.靶向缺氧诱导因子-1α治疗肝细胞癌
Cancers (Basel). 2023 May 12;15(10):2738. doi: 10.3390/cancers15102738.
3
Metformin and Cancer: Solutions to a Real-World Evidence Failure.二甲双胍与癌症:解决真实世界证据不足的问题
Diabetes Care. 2023 May 1;46(5):904-912. doi: 10.2337/dci22-0047.
4
A timeline of tumour-associated macrophage biology.肿瘤相关巨噬细胞生物学的时间线。
Nat Rev Cancer. 2023 Apr;23(4):238-257. doi: 10.1038/s41568-022-00547-1. Epub 2023 Feb 15.
5
Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 Response.靶向 xCT 介导的巨噬细胞铁死亡和促肿瘤极化可有效抑制 HCC 并增强抗 PD-1/L1 反应的疗效。
Adv Sci (Weinh). 2023 Jan;10(2):e2203973. doi: 10.1002/advs.202203973. Epub 2022 Nov 28.
6
Spatiotemporal co-dependency between macrophages and exhausted CD8 T cells in cancer.肿瘤微环境中耗竭 CD8+T 细胞与巨噬细胞的时空共依赖关系
Cancer Cell. 2022 Jun 13;40(6):624-638.e9. doi: 10.1016/j.ccell.2022.05.004. Epub 2022 May 26.
7
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.Claudin18.2 特异性 CAR T 细胞治疗胃肠道肿瘤的 1 期临床试验中期结果
Nat Med. 2022 Jun;28(6):1189-1198. doi: 10.1038/s41591-022-01800-8. Epub 2022 May 9.
8
The precursors of CD8 tissue resident memory T cells: from lymphoid organs to infected tissues.CD8 组织驻留记忆 T 细胞的前体:从淋巴器官到感染组织。
Nat Rev Immunol. 2022 May;22(5):283-293. doi: 10.1038/s41577-021-00590-3. Epub 2021 Sep 3.
9
Macrophage Polarization States in the Tumor Microenvironment.肿瘤微环境中的巨噬细胞极化状态。
Int J Mol Sci. 2021 Jun 29;22(13):6995. doi: 10.3390/ijms22136995.
10
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells in tumors.清道夫受体 CD36 摄取氧化脂质可促进肿瘤中 CD8 T 细胞的脂质过氧化和功能障碍。
Immunity. 2021 Jul 13;54(7):1561-1577.e7. doi: 10.1016/j.immuni.2021.05.003. Epub 2021 Jun 7.